Secretarial knowledge > plan book essay

Business plan book


market survey:
With the widespread use of disposable medical devices in China, the output of medical waste is increasing at a rate of 3% to 6% per year. In XX, there were 324,771 medical and health institutions nationwide, 3.177 million beds, and 2.123 billion person-times of medical treatment, generating about 1 million tons of medical waste. The UNEP Basel Convention has classified medical waste as hazardous waste that requires strict control of international transfers. China's National Hazardous Waste List also lists it as the number one hazardous waste. Because medical waste itself contains germs and viruses, if it is not properly handled, it will cause great harm to the environment and society.

Feasibility argument:
The “Encore” medical waste gas-controlled pyrolysis incineration and harmless integrated treatment device developed by Zhejiang University Thermal Energy Engineering Research Institute has overcome the obstacles of direct introduction of foreign technology for the complex and unclassified medical waste components in China. The harmless treatment of medical waste can not only reduce secondary pollution to a minimum level, but also recover heat energy, which has the dual advantages of low input and high social benefits.

The proposed “Ekolli Green Technology Co., Ltd.” will rely on the strong talents and technical strength of the Zhejiang University Thermal Energy Engineering Research Institute. In the early stage, it will take 3 to 5 years to flexibly use various financing methods to make it more developed in the more developed regions of the country. 20 to 30 medical waste treatment plants are established in medium-sized cities. While promoting the application of the existing Ekko medical waste treatment technology, it will accumulate funds and strengths and realize the diversified development of both technology and service methods. In the later period, the company will be established into a business scope throughout the country within 5 to 8 years, integrating environmental technology research, environmental equipment manufacturing, project engineering design and construction investment, involving medical waste treatment, urban hazardous domestic waste treatment, industrial hazardous waste treatment. A large environmental group company that advocates green living in various fields.

Return on investment:
The company intends to adopt the "bot" mode of operation, for a medical waste disposal enterprise with a processing capacity of 3,000 tons per year. In order to stabilize the business activities, the company needs to absorb 4 million yuan of external investment and invest 500,000 yuan of its own funds. The technology is priced at 1.5 million yuan. According to preliminary estimates, the company's internal rate of return is about 24%, and the investment payback period is three years and one month. Compared with the average profit margin of 10%, this level of profit is very satisfactory as an environmental protection company that benefits the country and the people.

The production idea of ​​high-purity medicinal melatonin: Market research of the “Dark Gold” entrepreneurial team of Zhejiang University:
Melatonin, the English name melatonin, is an endogenous hormone secreted by the mammalian pineal gland. When the melatonin is reduced, the body's various functions will be affected. Studies have shown that melatonin can effectively treat insomnia. In addition to adjusting the time difference, there are a variety of functions, as a raw material for health care products, with broad market development potential.

At present, the domestic market for melatonin raw materials is 6,000 kg, and it is expected to reach 10,000 kg in XX. At present, the annual production of melatonin in China is 1200 kg, and more than 90% of the market demand depends on imports, and the market capacity is huge.

Feasibility argument:
In this project, we use a new technological process to synthesize melatonin as a supplier of melatonin raw materials. Our technology has passed the pilot test, and the production amplification scheme has been certified by many well-known domestic chemical experts. It has the following advantages: high purity, simple process, high yield, low cost, cheap and easy raw materials, safe and environmentally friendly production.
Our customers are mainly health care products manufacturers with melatonin as raw materials. In the initial stage, we adopted the principle of concentration, directly targeting large customers with an annual demand of more than 50 kg. Our largest potential customer, Shanghai Jiante Company, has expressed this project. Great interest.

Return on investment:
We intend to establish p&e Pharmaceutical Raw Materials Research and Development Co., Ltd. with an investment of 7 million yuan, a net present value of investment of 13.7604 million yuan, an investment payback period of 1.51 years, and an internal rate of return of 76.38%.

recommended article

popular articles